Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity

Matthew C. Foster, Barbara Savoldo, Winnie Lau, Clio Rubinos, Natalie Grover, Paul Armistead, James Coghill, Robert S. Hagan, Kaitlin Morrison, Faith Brianne Buchanan, Catherine Cheng, Spencer Laing, Anastasia Ivanova, John West, Aaron Foster, Jonathan Serody, Gianpietro Dotti

Blood (2021) 137 (23): 3306–3309.

https://doi.org/10.1182/blood.2021010784

Published: 2021

Includes: Supplemental data

Journal Articles

Mechanism and Activity of ILC2 Cells Post Allo-BMT

Danny W Bruce, PhD, Heather E Stefanski, MD PhD, Benjamin G. Vincent, MD, Trisha Dant, BS, Shannon Reisdorf, BS, Hemamalini Bommiasamy, PhD, David Serody, Justin E Wilson, PhD, Karen McKinnon, PhD, Warren D Shlomchik, MD, Paul M. Armistead, MD PhD, Jenny PY Ting, PhD, John T Woosley, MD PhD, Dietmar MW Zaiss, PhD, Bruce R. Blazar, MD, Andrew NJ McKenzie, PhD, James Coghill, MD, Jonathan S. Serody, MD

Blood (2016) 128 (22): 1155.

https://doi.org/10.1182/blood.V128.22.1155.1155

Published: 2016

Journal Articles

Chronic GvHD Is Characterized By Impaired B Cell Development in the Bone Marrow

Oleg Kolupaev, PhD, Michelle West, BS, Bruce R. Blazar, MD, Stephen Tilley, MD, James Coghill, MD, Jonathan S. Serody, MD

Blood (2015) 126 (23): 1883.

https://doi.org/10.1182/blood.V126.23.1883.1883

Published: 2015

Journal Articles

Effect of Anti-Fungal Prophylaxis on the Fungal Mycobiome after Allogeneic Bone Marrow Transplantation

Shannon Reisdorf, BS, Hemamalini Bommiasamy, PhD, Michelle West, BS, David Serody, Danny Bruce, PhD, Benjamin G. Vincent, MD, James Coghill, MD, Jonathan S. Serody, MD

Blood (2015) 126 (23): 4290.

https://doi.org/10.1182/blood.V126.23.4290.4290

Published: 2015

Journal Articles

Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306

Reed Friend, MD, James Xenakis, Jonathan S Serody, MD, Terrance Comeau, MD, Don A. Gabriel, MD PhD, Stefanie Sarantopoulos, MD PhD, James Coghill, MD, William A. Wood, MD MPH, Andrew Sharf, Julia S Whitley, BS, Kamakshi Rao, PharmD, Christine M Walko, PharmD,BCOP, Anastasia Ivanova, PhD, Thomas C. Shea, MD, Paul M Armistead, MD PhD

Blood (2015) 126 (23): 3117.

https://doi.org/10.1182/blood.V126.23.3117.3117

Published: 2015

Journal Articles

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

Mathew Meeneghan, MD, Anna Snavely, PhD, Abbie Smith-Ryan, PhD, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Ethan Basch, MD MSc, Antonia Bennett, PhD, Charlotte Shatten, MA, Brett Phillips, BS, Jonathan Serody, MD, PhD, Don A. Gabriel, MD PhD, Katarzyna Joanna Jamieson, MD, James Coghill, MD, Paul M. Armistead, MD PhD, Thomas C. Shea, MD, William A. Wood, MD MPH

Blood (2014) 124 (21): 2611.

https://doi.org/10.1182/blood.V124.21.2611.2611

Published: 2014

Journal Articles

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Blood (2013) 122 (21): 910.

https://doi.org/10.1182/blood.V122.21.910.910

Published: 2013

Journal Articles

Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)

William A Wood, MD, MPH, Allison M Deal, MS, Bryce B Reeve, PhD, Amy P Abernethy, MD, Claudio L Battaglini, PhD, Yoon Hie Kim, BS, Julia S Whitley, BS, Charlotte Shatten, BS, Robert N Irons, PA, Amber N Essenmacher, PA, Kimberly Wehner, PA, Alicia Pinto, PA, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Jonathan S Serody, MD, Thomas C. Shea, MD

Blood (2012) 120 (21): 4471.

https://doi.org/10.1182/blood.V120.21.4471.4471

Published: 2012

Journal Articles

Feasibility and Prognostic Value of VO2 peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT)

William A Wood, MD, MPH, Allison M Deal, MS, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Amy P Abernethy, MD, Yoon Hie Kim, BS, Julia S Whitley, BS, Charlotte Shatten, BS, Robert N Irons, PA, Amber N Essenmacher, PA, Kimberly Wehner, PA, Alicia Pinto, PA, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Jonathan S Serody, MD, Thomas C. Shea, MD

Blood (2012) 120 (21): 4152.

https://doi.org/10.1182/blood.V120.21.4152.4152

Published: 2012

Journal Articles

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Blood (2012) 120 (12): 2529–2536.

https://doi.org/10.1182/blood-2012-06-438911

Published: 2012

Journal Articles

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

William A Wood, MD, MPH, Julia Whitley, BS, Ravi K Goyal, Paul M Brown, PhD, Andrew Sharf, Robert N Irons, PA, Kamakshi Rao, PharmD, Amber N Essenmacher, PA, Jonathan Serody, MD, James Coghill, MD, Paul M. Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Thomas C. Shea, MD

Blood (2011) 118 (21): 2083.

https://doi.org/10.1182/blood.V118.21.2083.2083

Published: 2011

Journal Articles

In Vivo Assessment of T Effector, T Regulatory Cell, Dendritic Cell Interaction in Lymphoid Tissue Using Intravital Imaging During Acute GvHD

Kaifeng Lisa Lin, PhD, Michelle L West, James Coghill, MD, Stephen Jones, James E Bear, PhD, Jonathan S Serody, MD

Blood (2011) 118 (21): 818.

https://doi.org/10.1182/blood.V118.21.818.818

Published: 2011

Journal Articles

Impaired Donor T Cell Egress From Recipient Lymphoid Tissue Profoundly Diminishes Acute GvHD,

LeShara M Fulton, BA, James Coghill, MD, Michelle L. West, BS, Niko Foger, PhD, James Bear, PhD, Jonathan S Serody, MD

Blood (2011) 118 (21): 4022.

https://doi.org/10.1182/blood.V118.21.4022.4022

Published: 2011

Journal Articles

Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies

Thomas C. Shea, MD, Christine Walko, PharmD, Anastasia Ivanova, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Don A. Gabriel, MD, PhD, Terrance Comeau, MD, FRCPC, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, William A. Wood, MD, MPH, Jonathan Serody, MD

Blood (2011) 118 (21): 1940.

https://doi.org/10.1182/blood.V118.21.1940.1940

Published: 2011

Journal Articles

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

LeShara M Fulton, BA, Michael J Carlson, PhD, James Coghill, MD, Michelle L. West, BS, Angela Panoskaltisis-Mortari, PhD, Bruce R. Blazar, MD, Dan Littman, PhD, Jonathan Serody, MD

Blood (2010) 116 (21): 3742.

https://doi.org/10.1182/blood.V116.21.3742.3742

Published: 2010

Journal Articles

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Don A. Gabriel, MD, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Charles van der Horst, MD, Jonathan Serody, MD, James Coghill, MD, Stefanie Sarantopoulos, MD, PhD, Paul Armistead, MD, PhD, William Wood, MD, MPH, Thomas C. Shea, MD

Blood (2010) 116 (21): 4550.

https://doi.org/10.1182/blood.V116.21.4550.4550

Published: 2010

Journal Articles

Successful Re-Engraftment after Second Allogeneic Transplantation for Graft Failure in Patients with Refractory Hematologic Malignancies.

Don A. Gabriel, MD, PhD, James Coghill, MD, Thomas C. Shea, MD, Terrance Comeau, MD, Robert Irons, P-AC, Carol Krasnov

Blood (2004) 104 (11): 5120.

https://doi.org/10.1182/blood.V104.11.5120.5120

Published: 2004

NARROW

Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity

Mechanism and Activity of ILC2 Cells Post Allo-BMT

Chronic GvHD Is Characterized By Impaired B Cell Development in the Bone Marrow

Effect of Anti-Fungal Prophylaxis on the Fungal Mycobiome after Allogeneic Bone Marrow Transplantation

Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)

Feasibility and Prognostic Value of VO2 peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT)

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

In Vivo Assessment of T Effector, T Regulatory Cell, Dendritic Cell Interaction in Lymphoid Tissue Using Intravital Imaging During Acute GvHD

Impaired Donor T Cell Egress From Recipient Lymphoid Tissue Profoundly Diminishes Acute GvHD,

Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Successful Re-Engraftment after Second Allogeneic Transplantation for Graft Failure in Patients with Refractory Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only